SeaStar Medical Holding Corporation

Healthcare · Biotechnology · United States

Last price 2.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.15M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SC...